Stoke Therapeutics (STOK) Price to FCF (2019 - 2026)
Powered by 
Analysis
Stoke Therapeutics (STOK) Price to FCF (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Stoke Therapeutics | 1.96 Bn | 1.66 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.87 |
| Mar 31, 2026 | -33.26 |
| Dec 31, 2025 | -60.95 |
| Sep 30, 2025 | -42.47 |
| Jun 30, 2025 | -24.28 |
| Mar 31, 2025 | 2.76 |
| Dec 31, 2024 | -25.65 |
| Sep 30, 2024 | -29.96 |
| Jun 30, 2024 | -40.33 |
| Mar 31, 2024 | -25.54 |
| Dec 31, 2023 | -11.57 |
| Sep 30, 2023 | -9.89 |
| Jun 30, 2023 | -21.11 |
| Mar 31, 2023 | -16.80 |
| Dec 31, 2022 | -15.98 |
| Sep 30, 2022 | -21.02 |
| Jun 30, 2022 | -25.24 |
| Mar 31, 2022 | 25.97 |
| Dec 31, 2021 | -53.56 |
| Sep 30, 2021 | -62.57 |